Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. Uwe Zeymer,
The session delt with recent developments in acute cardiac care.
Kurt Huber (Vienna, Austria) reported about the results of two studies dealing with the pre-hospital administration of antithrombotic drugs in patients with STEMI scheduled for primary PCI. In the prospective MULTIPRAC Registry patients with STEMI already diagnosed in the pre-hospital setting were included and received either clopidogrel or prasugrel. Both drugs were well tolerated and associated with a low rate of bleeding and in-hospital events after primary PCI, while prasugrel tended to be more effective with respect to myocardial reperfusion assessed by ST-segment resolution. In the EUROMAX trial pre-hospital treatment with monotherapy with bivalirudin compared to standard of care including heparins and GP IIb/IIIa inhibitors reduced the combined endpoint of mortality and bleeding until day 30. So both studies demonstrated that it is feasible, safe and effective to start antithrombotic therapy in STEMI already in the pre-hospital phase. Farzin Beguy (Caen, France) discussed unmet needs in pre-hospital care. While some work has been in patients with ACS, there is a lack of data about patients with dyspnea and syncope. There are no proven algorithms or treatment strategies for this important patient’s populations in the pre-hospital phase so far.
I. Nikolaou (Athens, Greece) summarized critically the current data on cooling after CPR. While earlier randomised trials showed a clear cut benefit of cooling after CPR for ventricular fibrillation, recent studies were more neutral. However, these studies compared cooling to 33 centigrade versus 36 centigrade, so none of the patients were left with fever. He therefore concluded that cooling still has an important place after pre-hospital CPR and should be initiated as soon as possible after CPR. The optimal method and temperature is still a matter of debate.
In the final talk, Hector Bueno (Madrid, Spain) summarized the activities and future plans of the Acute Cardiovascular Care Association (ACCA). This is the youngest association of the ESC and has rapidly grown up to more than 5000 members. It is the platform for all professionals involved in the care of acute cardiac patients. A major focus of ACCA is education with the ACCA toolkit, the ESCeL platform and the textbook, which second edition will appear during the next ACCA congress in Geneva in October 2014.
SessionTitle: A year in acute cardiac care - news from the pre-hospital and intensive care settings
© 2017 European Society of Cardiology. All rights reserved